Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, Arkansas.
Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Cancer Cytopathol. 2018 Aug;126(8):567-574. doi: 10.1002/cncy.22020. Epub 2018 May 24.
SMARCB1 (INI-1)-deficient sinonasal carcinoma (IDSNC) is a newly described, poorly differentiated carcinoma. Herein, the authors describe the cytopathologic features of IDSNC in fine-needle aspiration (FNA) samples.
The pathology archives of 2 academic institutions were searched for cases of IDSNC with available cytologic materials. All available slides were reviewed and a detailed morphological analysis was performed.
Six cases were identified from 6 patients. FNA specimens were obtained from metastatic sites (4 cases), a local disease recurrence (1 case), and a primary lesion extending into the orbit (1 case). The majority of cases had cellular specimens with features of nonkeratinizing squamous cell carcinoma composed of cohesive clusters and sheets of oval to polygonal cells with indistinct cell borders present within a background of necrotic debris. Two cases had single rhabdoid cells with more abundant cytoplasm. The nuclei generally were small and uniform with fine chromatin, small nucleoli, and mild nuclear membrane irregularities; moderate anisonucleosis and multinucleation were noted in one case. Apoptotic bodies were common in 5 of 6 cases, and readily identifiable mitoses in 3 of 6 cases. Immunohistochemistry demonstrated that all cases expressed cytokeratins, 4 of 5 cases expressed p63, and all cases demonstrated loss of INI-1 nuclear expression. All cases were negative for neuroendocrine markers and aberrant p16 staining.
A diagnosis of IDSNC can be suspected on FNA specimens from patients with high-grade sinonasal carcinomas that have either a nonkeratinizing squamous cell carcinoma or rhabdoid morphology. Clinical history and the availability of material for immunohistochemistry are key in confirming the diagnosis. Cancer Cytopathol 2018. © 2018 American Cancer Society.
SMARCB1(INI-1)缺陷型鼻鼻窦癌(IDSNC)是一种新描述的低分化癌。本文作者描述了细针抽吸(FNA)样本中 IDSNC 的细胞病理学特征。
作者在 2 所学术机构的病理档案中搜索了具有细胞学材料的 IDSNC 病例。对所有可用的切片进行了复习,并进行了详细的形态学分析。
从 6 名患者中确定了 6 例。FNA 标本来自转移部位(4 例)、局部疾病复发(1 例)和原发肿瘤延伸至眼眶(1 例)。大多数病例的细胞标本具有非角化鳞状细胞癌的特征,由黏附性簇和片状的椭圆形至多边形细胞组成,在坏死碎片背景下存在不明显的细胞边界。2 例有单个横纹样细胞,胞质更丰富。细胞核通常较小且均匀,染色质细,核小体小,核膜不规则轻微;1 例可见中度核异型性和多核。5 例中有 5 例可见凋亡小体,6 例中有 3 例可见易于识别的有丝分裂。免疫组织化学显示所有病例均表达细胞角蛋白,5 例中有 4 例表达 p63,所有病例均显示 INI-1 核表达缺失。所有病例均为神经内分泌标志物和异常 p16 染色阴性。
对于具有非角化鳞状细胞癌或横纹样形态的高级别鼻鼻窦癌患者,FNA 标本中可怀疑诊断为 IDSNC。临床病史和免疫组织化学材料的可用性是确诊的关键。癌症细胞病理学 2018. © 2018 美国癌症协会。